Onychomycosis (Tinea Unguium) Drug Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players, Applications And Forecast To 2028

Report Summary

Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Onychomycosis (Tinea Unguium) Drug market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.

Onychomycosis (Tinea Unguium) Drug market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

To learn more about this report

Request For Sample

Key Research Highlights: Market Drivers

The Onychomycosis (Tinea Unguium) Drug market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Onychomycosis (Tinea Unguium) Drug products across developed and developing countries of the world.

Key Research Highlights: Market Restrains

Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Onychomycosis (Tinea Unguium) Drug products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Onychomycosis (Tinea Unguium) Drug market.

To learn more about this report

Request For Sample

Key Research Highlights: Trends

Increasing research and development spending on Onychomycosis (Tinea Unguium) Drug development has been the leading industry trend of Onychomycosis (Tinea Unguium) Drug market

The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.

Global Onychomycosis (Tinea Unguium) Drug Market Size, 2018-2028 (USD MILLION)

To learn more about this report

Request For Sample

Market Segmentation

Report Attributes	Details
The market size value in 2021	USD XX.XX Million
CAGR (2021 - 2028)	XX.XX %
The Revenue forecast in 2028	USD XX.XX Million
Base year for estimation	2021
Historical data	2018-2019
Forecast period	2022-2028
Quantitative units	Revenue in USD Million CAGR from 2021 to 2028
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook	Oral Medication,External Medicine, Other
By Application Outlook	Age under 18,Age 18-50,Age above 50, Other
Regional scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope	U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled	GSK,Novartis,Pfizer,Valeant Pharma,Kaken Pharmaceutical,Galderma,Xiuzheng Pharmaceutical,Letai
Customization Available	Yes, the report can be tailored to meet your specific requirements.

Key Market Players

• GSK
• Novartis
• Pfizer
• Valeant Pharma
• Kaken Pharmaceutical
• Galderma
• Xiuzheng Pharmaceutical
• Letai

Onychomycosis (Tinea Unguium) Drug Market, By Type

• Oral Medication
• External Medicine
• Other

Onychomycosis (Tinea Unguium) Drug Market, By Application

• Age under 18
• Age 18-50
• Age above 50
• Other

Key Benefits To The Stake Holders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Table Of Contents

Table of Contents

Global Onychomycosis (Tinea Unguium) Drug Market Report 2020, Forecast to 2027

1 Scope of the Study
1.1 Onychomycosis (Tinea Unguium) Drug Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 Onychomycosis (Tinea Unguium) Drug Industry Overview
2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Onychomycosis (Tinea Unguium) Drug Global Import Market Analysis
2.1.2 Onychomycosis (Tinea Unguium) Drug Global Export Market Analysis
2.1.3 Onychomycosis (Tinea Unguium) Drug Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Oral Medication
2.2.2 External Medicine


2.3.2 Age 18-50
2.3.3 Age above 50


2.4.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Onychomycosis (Tinea Unguium) Drug Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share
2.4.5 Top 10 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Onychomycosis (Tinea Unguium) Drug Market
2.4.7 Key Manufacturers Onychomycosis (Tinea Unguium) Drug Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Onychomycosis (Tinea Unguium) Drug Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis

3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Onychomycosis (Tinea Unguium) Drug Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global Onychomycosis (Tinea Unguium) Drug Market Size Categorized by Regions
4.1 Global Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Market Share by Regions
4.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Regions (2015-2020)
4.2 Europe Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
4.3 APAC Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
4.4 North America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
4.5 South America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)

5 Europe Onychomycosis (Tinea Unguium) Drug Market Size Categorized by Countries
5.1 Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
5.1.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Countries (2015-2020)
5.1.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2015-2020)
5.1.3 Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
5.1.4 UK Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
5.1.5 France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
5.1.6 Russia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
5.1.7 Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
5.1.8 Spain Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
5.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
5.3.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)

6 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Categorized by Countries
6.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2015-2020)
6.1.3 China Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
6.1.4 Japan Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
6.1.5 Korea Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
6.1.6 India Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
6.1.8 Australia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2015-2020)

7 North America Onychomycosis (Tinea Unguium) Drug Market Size Categorized by Countries
7.1 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
7.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Countries (2015-2020)
7.1.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2015-2020)
7.1.3 United States Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
7.1.4 Canada Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
7.1.5 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
7.2 North America Onychomycosis (Tinea Unguium) Drug Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
7.3.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Type (2015-2020)
7.4 North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)

8 South America Onychomycosis (Tinea Unguium) Drug Market Size Categorized by Countries
8.1 South America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Onychomycosis (Tinea Unguium) Drug Sales by Countries (2015-2020)
8.1.2 South America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2015-2020)
8.1.3 Brazil Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
8.2 South America Onychomycosis (Tinea Unguium) Drug Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
8.3.2 South America Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Type (2015-2020)
8.4 South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)

9 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Categorized by Countries
9.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2015-2020)
9.1.3 GCC Countries Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
9.1.4 Turkey Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
9.1.5 Egypt Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
9.1.6 South Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)

10 Global Onychomycosis (Tinea Unguium) Drug Market Segment by Type
10.1 Global Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2015-2020)
10.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2015-2020)
10.2 Oral Medication Sales Growth Rate and Price
10.2.1 Global Oral Medication Sales Growth Rate (2015-2020)
10.2.2 Global Oral Medication Price (2015-2020)
10.3 External Medicine Sales Growth Rate and Price
10.3.1 Global External Medicine Sales Growth Rate (2015-2020)
10.3.2 Global External Medicine Price (2015-2020)


11.1 Global Onychomycosis (Tinea Unguium) DrugSales Market Share by Application (2015-2020)
11.2 Age under 18 Sales Growth Rate (2015-2020)
11.3 Age 18-50 Sales Growth Rate (2015-2020)
11.4 Age above 50 Sales Growth Rate (2015-2020)


12.1 Global Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2020-2027)
12.2 Onychomycosis (Tinea Unguium) Drug Market Forecast by Regions (2020-2027)
12.2.1 Europe Onychomycosis (Tinea Unguium) Drug Market Forecast (2020-2027)
12.2.2 APAC Onychomycosis (Tinea Unguium) Drug Market Forecast (2020-2027)
12.2.3 North America Onychomycosis (Tinea Unguium) Drug Market Forecast (2020-2027)
12.2.4 South America Onychomycosis (Tinea Unguium) Drug Market Forecast (2020-2027)
12.2.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Forecast (2020-2027)
12.3 Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2020-2027)
12.3.1 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2020-2027)
12.3.2 Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2020-2027)
12.4 Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2020-2027)
12.4.1 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2020-2027)
12.4.2 Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2020-2027)

13 Analysis of Onychomycosis (Tinea Unguium) Drug Industry Key Manufacturers
13.1 GSK
13.1.1 Company Details
13.1.2 Product Information
13.1.3 GSK Onychomycosis (Tinea Unguium) Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 GSK News
13.2 Novartis
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Novartis Onychomycosis (Tinea Unguium) Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Novartis News
13.3 Pfizer
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Pfizer Onychomycosis (Tinea Unguium) Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Pfizer News
13.4 Valeant Pharma
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Valeant Pharma News
13.5 Kaken Pharmaceutical
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Kaken Pharmaceutical News
13.6 Galderma
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Galderma Onychomycosis (Tinea Unguium) Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Galderma News
13.7 Xiuzheng Pharmaceutical
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Xiuzheng Pharmaceutical News
13.8 Letai
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Letai Onychomycosis (Tinea Unguium) Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Letai News



15 Appendix